Tuesday, 16 Oct 2018

You are here

Teriparatide Superior to Risedronate in the VERO Trial

Lancet reports that in a study teriparatide with risedronate, post-menopausal women with severe osteoporosis had significantly fewer new vertebral and clinical fractures on teriparatide comared to those receiving risedronate.

This trial is one of the first to compare osteoporosis drugs with incident fractures as the primary outcome.

Post-menopausal women (n=680) with more than one severe vertebral fracture and a BMD T score of less than or equal to −1·50 were enrolled to receive 20 μg of teriparatide (TER) daily or 35 mg of oral risedronate (RIS) once weekly for 24 months. The primary outcome was new radiographic vertebral fractures.

After 24 months, fewer new vertebral fractures (5·4%) were seen in the TER patients vs. RIS group (12·0%) (p<0·0001).

Clinical fractures were also decreased in the TER patients (4·8% vs. 9·8%). Non-vertebral fragility fractures were not significant but were also lowere (4% vs 6·1%). 

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Vitamin D Fails to Improve Bone Health

The current edition of Lancet Diabetes & Endocrinology suggests that neither vitamin D supplementation, nor dose, will improve bone density or prevent fractures in adults. (Citation source: https://buff.ly/2O9tqxI)

Zolendronic Acid Benefits Elder Women with Osteopenia

The NEJM reports that zolendronic acid was shown to significantly lower the risk of nonvertebral or vertebral fragility fractures in older women with osteopenia. 

Neuropathic Like Knee Pain

Fernandez and colleagues have shed further light on a significant subset of patients with knee pain - specifically, those with neuropathic like knee pain (NKP) that includes those with knee pain modified by central and peripheral neurologic dysfunction.

Knee Arthroscopic Surgeries on the Decline

A JAMA Internal Medicine report has shown that the rate of arthroscopic surgery has significantly declined, in an era when arthroplasty and the incidence of osteoarthritis (OA) has increased. (Citation source http://bit.ly/2DtpeUp)

Fractures May Lead to Systemic Bone Loss

Researchers at the University of California - Davis have shown that elderly women who had an upper body fracture or multiple fractures had more loss of hip density compared to those who who did not fracture. Systemic bone loss may increase the risk of future fractures.